netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 6 of 6


Details
UPD sitematrix Changed from 0 to
27/07/2022 08:48:48
(LoweryM )
UPD FurtherInformation Changed from

  • NETAG approved for use in the management of macular oedema
    secondary to retinal vein occlusion. This is considered a more cost
    effective treatment option in RVO compared with ranibizumab.
27/07/2022 08:48:48
(LoweryM )
UPD Bevacizumab 1.25mg/0.5ml intravitreal injection updated
27/07/2022 08:48:48
(LoweryM )
UPD Bevacizumab 1.25mg/0.5ml intravitreal injection updated
19/05/2021 16:12:18
(DavidS )
UPD Bevacizumab 1.25mg/0.5ml intravitreal injection updated
16/03/2017 16:32:02
(LoweryM )
UPD Bevacizumab 1.25mg/0.5ml intravitreal injection (Avastin®) build
17/01/2017 09:49:50
(DavidS )

 

 
netFormulary